Skip to main content
SYRE
NASDAQ Life Sciences

Spyre Therapeutics Closes $463.5M Public Offering, Underwriters Fully Exercise Option

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$69.76
Mkt Cap
$5.474B
52W Low
$12.04
52W High
$75
52W Position info
479% above low
Off High info
7.0% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

SYRE has more than doubled off its 52-week low of $12.04 on elevated volume (2.4× avg).

Summary

Spyre Therapeutics announced the successful closing of its previously announced public offering, generating gross proceeds of $463.5 million. This includes the full exercise of the underwriters' option to purchase additional shares, indicating strong investor demand. This event follows the company's announcement of a proposed offering on April 13th and its subsequent upsizing and pricing on April 15th. The substantial capital infusion significantly bolsters Spyre's cash position, providing a robust runway to advance its clinical pipeline, particularly after the recent positive Phase 2 data for SPY001. While the offering is dilutive, it ensures long-term operational stability for the clinical-stage biotechnology company. Investors will now monitor the strategic deployment of these funds and further progress in clinical development.

At the time of this announcement, SYRE was trading at $69.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.5B. The 52-week trading range was $12.04 to $75.00. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

SYRE - Latest Insights

SYRE
Nov 03, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $99.73
Real-time Price: $96.76 info
Change: -$2.97 (-3%) info
Market Cap: $9.189B info
SYRE
Nov 03, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $99.73
Real-time Price: $96.76 info
Change: -$2.97 (-3%) info
Market Cap: $9.189B info
SYRE
Oct 07, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $80.51
Real-time Price: $96.76 info
Change: +$16.25 (+20%) info
Market Cap: $9.189B info
SYRE
Oct 06, 2026, 4:41 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $80.11
Real-time Price: $96.76 info
Change: +$16.65 (+21%) info
Market Cap: $9.189B info
SYRE
Oct 06, 2026, 11:53 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $81.16
Real-time Price: $96.76 info
Change: +$15.60 (+19%) info
Market Cap: $9.189B info